As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Fitzwilliam
Engaged Reader
2 hours ago
Free US stock comparative valuation tools and peer analysis to identify mispriced securities in the market. We help you understand relative value across different metrics and time periods to find the best opportunities.
👍 179
Reply
2
Athyna
Registered User
5 hours ago
This feels like something I’ll think about later.
👍 15
Reply
3
Shehzeen
Legendary User
1 day ago
This feels like something is off but I can’t prove it.
👍 132
Reply
4
Shenkia
Legendary User
1 day ago
This feels like I’m late to something.
👍 200
Reply
5
Madline
Legendary User
2 days ago
Highlights key factors influencing market sentiment clearly.
👍 124
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.